Trials / Terminated
TerminatedNCT03380273
AO Multicenter Intervention Trial for Prevention of Surgical Site Infection
AO Multicenter Intervention Trial to Evaluate the Impact of a Bundle of Measures for the Prevention of Surgical Site Infection in Fracture Patients
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 222 (actual)
- Sponsor
- AO Clinical Investigation and Publishing Documentation · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
This study is designed to collect data from 8,476 fracture patients during a pre-and post-intervention phases of two years length each. The intervention consists on the implementation of the AOT SSI Prevention Bundle. D
Detailed description
During the first phase of the study, 4,238 patients will be recruited and the baseline incidence of surgical site infection at each participating site will be determined. At the beginning of the third year, the bundle will be implemented and data on 4,238 additional patients will be collected. The incidence rate on surgical site infection before and after the intervention will be compared. We hypothesize that this intervention will reduce the infection rate within the first 3 months after surgery from 6% to 4.5% (5% to 3.75% in closed fractures and from 10% to 7.5% in open fractures).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Implementation of the AO Trauma SSI Prevention Bundle | AOT SSI Prevention Bundle Preventive measure 1. Antibiotic prophylaxis 2. Perioperative antibiotics 3. Oxygen administration 4. Patient temperature 5. Surgeon protective wear 6. Patient operative skin preparation 7. Suction drains 8. Blood glucose level 9. Red cell transfusion 10. Dressing changes |
Timeline
- Start date
- 2019-12-06
- Primary completion
- 2021-12-30
- Completion
- 2021-12-31
- First posted
- 2017-12-21
- Last updated
- 2022-01-18
Locations
14 sites across 6 countries: United States, Argentina, Germany, Romania, South Korea, Spain
Source: ClinicalTrials.gov record NCT03380273. Inclusion in this directory is not an endorsement.